Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer
Rieneke van de Ven(Oncode Institute), Bernard A. Fox(Oregon Health & Science University)
Cited by 5
Related Papers
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
|Clinical Cancer Research|2011|109
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
|Journal for ImmunoTherapy of Cancer|2020|93
Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer
|Journal for ImmunoTherapy of Cancer|2021|26